Insilico Medicine, an end-to-end artificial intelligence (AI)-powered drug discovery company, announced the appointment of Nirav Jhaveri as Chief Financial Officer (CFO) to oversee capital markets, investor relations, financial operations, and corporate development. “It is an honor to join a pioneering company at the forefront of innovation in drug discovery. Insilico is leveraging its AI platform to accelerate…